Who Dominates the Photocatalytic Oxidation Air Purifiers Market? Top Players According to a newly published market research report by 24LifeSciences, global photocatalytic oxidation air purifier market was valued at USD 315 million in 2024 and is projected to reach USD 502 million by 2031, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period 20252031. Photocatalytic oxidation (PCO) technology utilizes UV-activated semiconductors to break down volatile organic compounds (VOCs), bacteria, and viruses into harmless compounds like CO2 and water. This technology has gained significant traction due to increasing concerns about indoor air quality (IAQ) and its proven effectiveness against airborne pathogens across residential, commercial, and healthcare environments. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5184/photocatalytic-oxidation-air-purifiers-market

Global Women’s Health & Beauty Vitamin Supplements Market Forecast 2025 According to a newly published market research report by 24LifeSciences, global womens health and beauty vitamin supplements market was valued at USD 9.58 billion in 2024 and is projected to reach USD 15.85 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period 20252031. Womens health and beauty vitamin supplements are specialized nutritional formulations designed specifically to address women's unique physiological needs and beauty enhancement goals. These supplements typically feature comprehensive blends of vitamins A, B-complex, C, D, and E, complemented by essential minerals like zinc and selenium. The market has evolved to include sophisticated formulations containing specialized ingredients such as biotin, collagen, hyaluronic acid, and targeted antioxidants that address specific beauty concerns. These products represent the growing convergence of wellness and beauty, offering internal nutrition solutions that support external appearance and overall health. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5212/womens-health-and-beauty-vitamin-supplements-market

Anatomical Models Market Forecast to 2032: Revenue, Share & Key Insights According to a newly published market research report by 24LifeSciences, global anatomical models market was valued at USD 48.1 million in 2024 and is projected to reach USD 52.1 million by 2031, growing at a compound annual growth rate (CAGR) of 1.2% during the forecast period 2025-2031. Anatomical models are three-dimensional representations used to study and explain the internal and external structures of the human body or animals, as well as the functions of various physiological systems. These models are critical educational tools, providing tangible, realistic references for students, doctors, professors, and other healthcare professionals. The product range is extensive, including skeleton and muscular models, dental models, head and skull models, torso and organ models, and veterinary models, among others. Their established efficacy in hands-on learning continues to underpin their importance in medical education, surgical planning, and patient communication. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6555/anatomical-models-market-market

What Is the Future of the Tonometer Market? 2025–2032 Growth Outlook According to a newly published market research report by 24LifeSciences, global tonometer market was valued at USD 207 million in 2024 and is projected to reach USD 287 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period 2025–2031. A tonometer is a critical medical instrument used for measuring intraocular pressure (IOP) by exploiting the eye's physical properties, allowing for non-invasive assessment without cannulation. This measurement is a cornerstone in diagnosing and managing glaucoma, a leading cause of irreversible blindness. Key product types include applanation tonometerswhich flatten a small area of the corneaand rebound tonometers that measure the deceleration of a gentle probe contacting the cornea, available as hand-held and desktop variants for different clinical settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6747/tonometer-market-market

Optic Neuropathy Management Market Trends, Opportunities & Forecast 2032 According to a newly published market research report by 24LifeSciences, global optic neuropathy management market was valued at USD 4,362 million in 2024 and is projected to reach USD 6,255 million by 2031, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period 2025–2031. Optic neuropathy encompasses a group of conditions characterized by damage to the optic nerve, which transmits visual information from the eye to the brain. These disorders, which include glaucomatous, inflammatory, and ischemic neuropathies, can lead to progressive and often irreversible vision loss if not managed effectively. The established importance of early diagnosis and intervention continues to underpin the critical need for advanced management strategies in ophthalmology and neurology. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4366/optic-neuropathy-management-market

Top 10 Companies Leading the Non-Replicating mRNA Vaccine Market Growth According to a newly published market research report by 24LifeSciences, global non-replicating mRNA vaccine market was valued at USD 1.34 billion in 2024 and is projected to reach USD 2.32 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025-2032. Non-replicating mRNA vaccines represent a novel class of therapeutics based on messenger RNA technology, characterized by mRNA that does not replicate within the recipient's body. These vaccines work by delivering mRNA encoding specific antigens to human cells, prompting them to produce protein fragments that subsequently stimulate the immune system to generate both antibody production and T-cell activation. Due to their non-replicating nature, these vaccines are considered highly safe as they cannot cause infection or disease. The technology demonstrated significant advantages during the COVID-19 pandemic, establishing itself as a platform capable of rapid response to emerging health threats. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5190/non-replicating-mrna-vaccine-market

Afatinib Dimaleate Tablets Market to Grow at 6.3% CAGR Through 2031 According to a newly published market research report by 24LifeSciences, global Afatinib Dimaleate tablets market was valued at USD 971 million in 2024 and is projected to reach USD 1.49 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period. Afatinib dimaleate is an oral, small-molecule, irreversible tyrosine kinase inhibitor (TKI) that specifically targets EGFR, HER2, and HER4 signaling pathways. Its mechanism of action involves covalent binding to these receptors, providing sustained inhibition even after drug clearance. Clinical trials have repeatedly demonstrated significant efficacy in first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC), establishing it as a cornerstone therapy in precision oncology. The drug's established clinical profile and expanding approvals across global regulatory bodies continue to reinforce its critical role in modern cancer treatment protocols. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5178/afatinib-dimaleate-tablets-market

Who Dominates the HFNC Therapy Systems Market? Top Players Revealed According to a newly published market research report by 24LifeSciences, global High Flow Nasal Cannula Therapy Systems market was valued at USD 577 million in 2025 and is projected to reach USD 900 million by 2032, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period 2025–2032. High Flow Nasal Cannula (HFNC) Therapy Systems are sophisticated non-invasive respiratory support devices that deliver precisely heated, humidified, and blended air-oxygen mixtures at flow rates significantly higher than conventional oxygen therapy. By effectively washing out anatomical dead space and providing a slight positive airway pressure, these systems dramatically improve oxygenation and reduce the work of breathing for patients with acute and chronic respiratory failure. This technology has become a cornerstone in modern respiratory care, bridging the gap between standard oxygen delivery and more invasive mechanical ventilation. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12630/high-flow-nasal-cannula-therapy-systems-market

Smart Insulin Pens Market Outlook: Opportunities & Innovation Trends According to a newly published market research report by 24LifeSciences, global Smart Insulin Pens market was valued at USD 12 million in 2024 and is projected to reach USD 22 million by 2032, growing at a compound annual growth rate (CAGR) of 9.3% during the forecast period 2025–2032. Smart Insulin Pens represent a transformative advancement in diabetes management, combining traditional insulin delivery with digital connectivity and data tracking capabilities. These innovative devices feature Bluetooth technology, dose memory functions, and mobile app integration to help patients monitor insulin administration, receive dosage reminders, and share data with healthcare providers. Their ability to improve medication adherence and provide valuable treatment insights has positioned them as critical tools in modern diabetes care, particularly valuable for both Type 1 and insulin-dependent Type 2 diabetes patients. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1061/smart-insulin-pens-market

Head Lice Infestation Drug Market to Grow at 3.6% CAGR Through 2032 According to a newly published market research report by 24LifeSciences, global head lice infestation drug market was valued at USD 372 million in 2024 and is projected to reach USD 473 million by 2031, growing at a compound annual growth rate (CAGR) of 3.6% during the forecast period 2025–2031. Head lice infestation drugs, clinically known as pediculicides, are specialized pharmaceutical treatments designed to eradicate Pediculus humanus capitis infestations. These products work through various mechanisms including neurotoxicity, physical suffocation, or enzymatic disruption to eliminate live lice and their eggs (nits). Common formulations include shampoos, lotions, creams, and topical solutions, with shampoo-based products holding the dominant market share due to their ease of application and consumer familiarity. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7268/head-lice-infestation-drug-market